GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » COGS-to-Revenue

WIN-Partners Co (TSE:3183) COGS-to-Revenue : 0.88 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co COGS-to-Revenue?

WIN-Partners Co's Cost of Goods Sold for the three months ended in Dec. 2023 was 円17,290 Mil. Its Revenue for the three months ended in Dec. 2023 was 円19,716 Mil.

WIN-Partners Co's COGS to Revenue for the three months ended in Dec. 2023 was 0.88.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. WIN-Partners Co's Gross Margin % for the three months ended in Dec. 2023 was 12.30%.


WIN-Partners Co COGS-to-Revenue Historical Data

The historical data trend for WIN-Partners Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co COGS-to-Revenue Chart

WIN-Partners Co Annual Data
Trend Mar12 Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.87 0.88 0.87 0.88

WIN-Partners Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.88 0.88 0.88 0.88

WIN-Partners Co COGS-to-Revenue Calculation

WIN-Partners Co's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=62192.234 / 70854.47
=0.88

WIN-Partners Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=17290.293 / 19715.525
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WIN-Partners Co  (TSE:3183) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

WIN-Partners Co's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 17290.293 / 19715.525
=12.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


WIN-Partners Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


WIN-Partners Co (TSE:3183) Business Description

Traded in Other Exchanges
N/A
Address
2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines